Neuronetics Revenue Rises as Clinic Business Expands
MALVERN, PA — Neuronetics (NASDAQ: STIM) reported higher first-quarter revenue driven by growth in its U.S. clinic operations following the Greenbrook acquisition, while the company narrowed losses and reduced cash …
Neuronetics Revenue Rises as Clinic Business Expands Read More